Eyefill gel devices pass safety check in cataract surgery study

NCT ID NCT06767917

Completed Disease control Sponsor: Bausch & Lomb GmbH Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two gel-like devices, Eyefill SC and Eyefill MB, used during cataract surgery to protect the eye. Researchers followed 148 adults who had cataract surgery with these devices to see if they were safe and worked as intended. The main focus was on changes in the eye's inner lining cells after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Eyefill SC and Eyefill MB (viscoelastic devices used during cataract surgery)
What this could lead to: If successful, this study confirms that these devices are safe and work well for protecting the eye during cataract surgery.
What could go wrong: This is a small, completed post-market study with no comparison group, so results may not apply to all patients or detect rare complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Locations

Site 102

Madrid, Madrid, 28040, Spain
Site 103

Zaragoza, Spain, 50004, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.